These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32191978)

  • 41. Antibiotic stewardship in low- and middle-income countries: the same but different?
    Cox JA; Vlieghe E; Mendelson M; Wertheim H; Ndegwa L; Villegas MV; Gould I; Levy Hara G
    Clin Microbiol Infect; 2017 Nov; 23(11):812-818. PubMed ID: 28712667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of antimicrobial resistance on health outcomes in the out-patient treatment of adult community-acquired pneumonia: a probability model.
    Singer ME; Harding I; Jacobs MR; Jaffe DH
    J Antimicrob Chemother; 2003 May; 51(5):1269-82. PubMed ID: 12697646
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial Stewardship Programs: Principles and Practice.
    Cunha CB
    Med Clin North Am; 2018 Sep; 102(5):797-803. PubMed ID: 30126571
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Community-acquired pneumonia: reality revisited.
    Cunha BA
    Am J Med; 2000 Apr; 108(5):436-8. PubMed ID: 10759108
    [No Abstract]   [Full Text] [Related]  

  • 45. [Antibiotic Stewardship - From Bench to Bedside].
    Ortlepp JR
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2017 Apr; 52(4):260-273. PubMed ID: 28470636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The extent of microbiological testing is associated with alteration of antibiotic therapy in adults with community-acquired pneumonia.
    Wittermans E; Vestjens SMT; Bos WJW; Grutters JC; van de Garde EMW; Vlaminckx BJM
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1359-1366. PubMed ID: 31025133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical efficacy of newer agents in short-duration therapy for community-acquired pneumonia.
    File TM
    Clin Infect Dis; 2004 Sep; 39 Suppl 3():S159-64. PubMed ID: 15546111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A critical assessment of published guidelines and other decision-support systems for the antibiotic treatment of community-acquired respiratory tract infections.
    Finch RG; Low DE
    Clin Microbiol Infect; 2002; 8 Suppl 2():69-91. PubMed ID: 12427208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patient packs and the prescribing of antimicrobial agents.
    Humphreys H; Walley T
    J Antimicrob Chemother; 1996 Sep; 38(3):329-31. PubMed ID: 8889710
    [No Abstract]   [Full Text] [Related]  

  • 50. [Short course antibiotic treatment during community acquired pneumonia: Review of the literature and perspectives].
    Philippot Q; Dinh A; Voiriot G
    Rev Mal Respir; 2020 Jan; 37(1):26-33. PubMed ID: 31883818
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial therapy for community-acquired pneumonia in adults.
    da Cunha CA; Sader HS; Nicodemo AC;
    Braz J Infect Dis; 2002 Apr; 6(2):82-7. PubMed ID: 11980608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Community-acquired pneumonia.
    Polverino E; Torres Marti A
    Minerva Anestesiol; 2011 Feb; 77(2):196-211. PubMed ID: 21242952
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluating the impact of an antimicrobial stewardship program on the length of stay of immune-competent adult patients admitted to a hospital ward with a diagnosis of community-acquired pneumonia: A quasi-experimental study.
    DiDiodato G; McArthur L; Beyene J; Smieja M; Thabane L
    Am J Infect Control; 2016 May; 44(5):e73-9. PubMed ID: 26899527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Review of treatment guidelines for community-acquired pneumonia.
    Niederman MS
    Am J Med; 2004 Aug; 117 Suppl 3A():51S-57S. PubMed ID: 15360097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
    Heffelfinger JD; Dowell SF; Jorgensen JH; Klugman KP; Mabry LR; Musher DM; Plouffe JF; Rakowsky A; Schuchat A; Whitney CG
    Arch Intern Med; 2000 May; 160(10):1399-408. PubMed ID: 10826451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of an emergency medicine pharmacist on empiric antibiotic prescribing for pneumonia and intra-abdominal infections.
    Kulwicki BD; Brandt KL; Wolf LM; Weise AJ; Dumkow LE
    Am J Emerg Med; 2019 May; 37(5):839-844. PubMed ID: 30097272
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Community acquired bacterial pneumonia.
    Anevlavis S; Bouros D
    Expert Opin Pharmacother; 2010 Feb; 11(3):361-74. PubMed ID: 20085502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Community-acquired pneumonia caused by Enterobacter asburiae.
    Stewart JM; Quirk JR
    Am J Med; 2001 Jul; 111(1):82-3. PubMed ID: 11460856
    [No Abstract]   [Full Text] [Related]  

  • 59. In Data We Trust? Comparison of Electronic Versus Manual Abstraction of Antimicrobial Prescribing Quality Metrics for Hospitalized Veterans With Pneumonia.
    Jones BE; Haroldsen C; Madaras-Kelly K; Goetz MB; Ying J; Sauer B; Jones MM; Leecaster M; Greene T; Fridkin SK; Neuhauser MM; Samore MH
    Med Care; 2018 Jul; 56(7):626-633. PubMed ID: 29668648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimicrobial Resistance: An Antimicrobial/Diagnostic Stewardship and Infection Prevention Approach.
    Septimus EJ
    Med Clin North Am; 2018 Sep; 102(5):819-829. PubMed ID: 30126573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.